| scholarly article | Q13442814 |
| P50 | author | Angela Tincani | Q73304219 |
| P2093 | author name string | Ilaria Cavazzana | |
| Monica Nuzzo | |||
| Renato Alberto Sinico | |||
| Pietro Napodano | |||
| Patrizia Scaini | |||
| Monica Vianelli | |||
| P2860 | cites work | A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group | Q29614889 |
| Antiphospholipid antibody syndrome and renal disease | Q32064111 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| "Black swan in the kidney": renal involvement in the antiphospholipid antibody syndrome | Q33343576 | ||
| Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis | Q33358476 | ||
| The "primary" antiphospholipid syndrome: major clinical and serological features. | Q33416915 | ||
| Membranous nephropathy in primary antiphospholipid syndrome: description of a case and induction of renal injury in SCID mice | Q33498624 | ||
| International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop | Q33685960 | ||
| Renal involvement in antiphospholipid syndrome | Q34377489 | ||
| Antiphospholipid syndrome nephropathy | Q34873953 | ||
| The expanding spectrum of renal diseases associated with antiphospholipid syndrome | Q35140898 | ||
| Primary antiphospholipid syndrome: a distinct entity? | Q36336277 | ||
| Antiphospholipid syndrome and the kidneys | Q36502421 | ||
| Identification of antibodies to acidic antigens by counterimmunoelectrophoresis | Q41131863 | ||
| Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group | Q43654524 | ||
| Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. | Q43829967 | ||
| Renal involvement in primary antiphospholipid syndrome and its response to immunosuppressive therapy | Q44641118 | ||
| Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis. | Q52866849 | ||
| Renal manifestations of the antiphospholipid syndrome | Q58622220 | ||
| Renal involvement in primary antiphospholipid syndrome | Q67908661 | ||
| Anti-cardiolipin antibody and renal disease: a report three cases | Q68398056 | ||
| [Antiphospholipid antibodies in systemic lupus erythematosus: incidence, significance and relation to lupus nephritis] | Q69217363 | ||
| The anticardiolipin syndrome | Q69573545 | ||
| Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythmatosus | Q70103723 | ||
| Purification and characterization of the Sjögren's syndrome A and B antigens | Q70307037 | ||
| Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH | Q70897451 | ||
| Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome? | Q72345769 | ||
| Idiopathic membranous glomerulonephritis associated with primary antiphospholipid syndrome | Q73236235 | ||
| Lack of association between antiphospholipid antibody and WHO classification in lupus nephritis | Q73611473 | ||
| Massive proteinuria as a main manifestation of primary antiphospholipid syndrome | Q74522812 | ||
| The intrarenal vascular lesions associated with primary antiphospholipid syndrome | Q74597824 | ||
| The antiphospholipid syndrome | Q77739053 | ||
| Autoantibody explosion in antiphospholipid syndrome | Q80436378 | ||
| Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity? | Q80484528 | ||
| Pathogenesis of the antiphospholipid syndrome: an additional example of the mosaic of autoimmunity | Q80491746 | ||
| P433 | issue | 7 | |
| P921 | main subject | antiphospholipid syndrome | Q582207 |
| primary antiphospholipid syndrome | Q63878006 | ||
| P304 | page(s) | 1211-1217 | |
| P577 | publication date | 2010-04-29 | |
| P1433 | published in | Clinical Journal of the American Society of Nephrology | Q15757929 |
| P1476 | title | Renal involvement in primary antiphospholipid syndrome: retrospective analysis of 160 patients | |
| P478 | volume | 5 |
| Q33437339 | A 3-year follow-up of a patient with acute renal failure caused by thrombotic microangiopathy related to antiphospholipid syndrome: case report |
| Q92165945 | A case of lupus vasculopathy presenting favorable renal outcome |
| Q51144375 | Abdominal pain, flank pain, blurry vision, and lower extremity weakness in a 16-year-old female. |
| Q55177568 | Antiphospholipid Syndrome Nephropathy: From Pathogenesis to Treatment. |
| Q90312460 | Antiphospholipid Syndrome and Kidney Involvement: New Insights |
| Q41808505 | Antiphospholipid antibodies and systemic scleroderma |
| Q33413394 | Antiphospholipid syndrome in renal transplantation |
| Q38162724 | Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study |
| Q83286182 | Antiphospholipid syndrome: unusual clinical presentations |
| Q42086661 | Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea |
| Q33423959 | Current treatment of antiphospholipid syndrome: lights and shadows |
| Q42289871 | Hemodiafiltration for hepatic encephalopathy induced by Budd-Chiari syndrome in a patient with end-stage kidney disease |
| Q38934375 | Kidney disease in primary anti-phospholipid antibody syndrome |
| Q55407136 | Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications. |
| Q37476122 | Prevalence of anti- beta2GPI antibodies and their isotypes in patients with renal diseases and clinical suspicion of antiphospholipid syndrome |
| Q33394629 | Primary antiphospholipid syndrome presenting as renal vein thrombosis and membranous nephropathy |
| Q35351368 | Primary antiphospholipid syndrome presenting as thrombotic microangiopathy: Successful treatment with steroids, plasma exchange and anticoagulants |
| Q87204631 | Rare association of cutaneous vasculitis, IgA nephropathy and antiphospholipid antibody syndrome with tuberculous lymphadenitis |
| Q54967401 | Renal Involvement in Antiphospholipid Syndrome. |
| Q86984388 | Renal involvement in antiphospholipid syndrome |
| Q87467570 | Renal involvement in antiphospholipid syndrome |
| Q88581290 | Renal involvement in antiphospholipid syndrome |
| Q34654954 | Renal involvement in autoimmune connective tissue diseases |
| Q38838855 | Renal involvement in primary antiphospholipid syndrome |
| Q30701440 | Reversible cerebral vasoconstriction syndrome (RCVS) in antiphospholipid antibody syndrome (APLA): the role of centrally acting vasodilators. Case series and review of literature |
| Q38222239 | Rheumatological diseases and kidneys: a nephrologist's perspective |
| Q33833470 | The challenges of antiphospholipid syndrome: experience from diagnosis to self-care |
| Q49906802 | The role of the immune system in kidney disease |
| Q84378946 | [Renal emergencies in cases of collagenosis and vasculitis] |
Search more.